Jefferies on Savara (SVRA): 'We remain 90% confident in Molbreevi's US approval by Aug 22, 2026'
Jefferies on Savara (NASDAQ: SVRA): 'We remain 90% confident in Molbreevi's US approval by Aug 22, 2026'.The analyst comments ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
